Eag1 Potassium Channel Expression in Soft Tissue Sarcoma
Author Information
Author(s): Fernanda Mello de Queiroz, Guilherme Suarez-Kurtz, Walter Stühmer, Luis A Pardo
Primary Institution: Instituto Nacional do Câncer
Hypothesis
What is the frequency of Eag1 expression in soft tissue sarcomas and its potential clinical implications?
Conclusion
Eag1 is expressed in over 70% of sarcomas, and inhibiting its expression reduces the proliferation of sarcoma cell lines.
Supporting Evidence
- Eag1 was expressed in 71% of all tumors studied.
- Expression levels varied by histological type, with rhabdomyosarcoma showing the highest frequency.
- Inhibition of Eag1 led to reduced proliferation in sarcoma cell lines.
Takeaway
Most soft tissue sarcomas have a special protein called Eag1 that helps them grow, and stopping this protein can slow down their growth.
Methodology
Immunohistochemistry was used to assess Eag1 expression in tumor samples from 210 patients.
Potential Biases
The detection method may miss some Eag1 expressions due to its low sensitivity.
Limitations
Samples stored for more than two years may give unreliable results due to antigen degradation.
Participant Demographics
Patients included were from the Brazilian National Cancer Institute, with a variety of soft tissue sarcoma types.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website